All In MedTech

FDA Clearance Tracker · P080006-S014

ATTAIN ABILITY MODEL 4196 LEFT VENTRICULAR LEAD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 13, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 13, 2011

Approved

Time to decision

143 days

Received Aug 23, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P080006-S014
Device name
ATTAIN ABILITY MODEL 4196 LEFT VENTRICULAR LEAD
Applicant location
Minneapolis, MN
Received
Aug 23, 2010
Decided
Jan 13, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P080006

Device type

Device class
Class III

Every decision under product code OJX

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.